Biogen Inc Stock Investor Sentiment
| BIIB Stock | USD 194.11 0.27 0.14% |
About 70% of Biogen's investor base is looking to short. The analysis of the overall investor sentiment regarding Biogen Inc suggests that many traders are alarmed. Biogen's investor sentiment overview provides quick insight into current market opportunities from investing in Biogen Inc. The current market sentiment, together with Biogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Biogen Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
30
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Biogen's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Biogen Inc.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Biogen stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Biogen daily returns and investor perception about the current price of Biogen Inc as well as its diversification or hedging effects on your existing portfolios.
Biogen Historical Sentiment
Although Biogen's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Biogen, such as negative comments on social media and news outlets, may cause fear in the market and push Biogen's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Biogen.
Biogen |
Biogen Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Biogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biogen Inc Historical Investor Sentiment
Investor biases related to Biogen's public news can be used to forecast risks associated with an investment in Biogen. The trend in average sentiment can be used to explain how an investor holding Biogen can time the market purely based on public headlines and social activities around Biogen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biogen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biogen and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Biogen news discussions. The higher the estimate score, the more favorable the investor's outlook on Biogen.
Biogen Maximum Pain Price across 2024-04-26 Option Contracts
Biogen's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Biogen close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Biogen's options.
Far too much social signal, news, headlines, and media speculation about Biogen that are available to investors today. That information is available publicly through Biogen media outlets and privately through word of mouth or via Biogen internal channels. However, regardless of the origin, that massive amount of Biogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biogen alpha.
Biogen Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Disposition of 634 shares by Ginger Gregory of Biogen at 240.98 subject to Rule 16b-3 | 03/08/2024 |
2 | European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimers Drug Lecanemab | 03/22/2024 |
3 | Omega Therapeutics, Inc. Reports Q4 Loss, Tops Revenue Estimates | 03/28/2024 |
4 | Disposition of tradable shares by Singhal Priya of Biogen at 213.09 subject to Rule 16b-3 | 04/03/2024 |
5 | A Tale of Two Investors, Which One Are You | 04/05/2024 |
6 | INVESTOR CALLVirtualwares CEO to present Annual Report to shareholders | 04/11/2024 |
7 | Global Pulmonary Fibrosis Biomarkers Market Size To Exceed USD 6.1 Billion By 2033 CAGR of 4.3 | 04/12/2024 |
8 | Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer | 04/15/2024 |
9 | Medicare spending on Biogens Alzheimers drug to hit 3.5B | 04/16/2024 |
10 | STAT Pharmalittle Were reading about Lillys Zepbound for sleep apnea, the FDA budget, and more | 04/17/2024 |
11 | Biogen Unusual Options Activity For April 18 | 04/18/2024 |
12 | Gear Up for Biogen Q1 Earnings Wall Street Estimates for Key Metrics | 04/19/2024 |
Check out Biogen Hype Analysis, Biogen Correlation and Biogen Performance. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 7.96 | Revenue Per Share 67.972 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0458 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.